Several studies[36] have indicated that PUFAs can facilitate the conformational alteration and polymerization of Tau protein, thereby confirming the involvement of lipids in the brain lesions associated with Tau protein in AD patients. The gene discussed is MAPT; the disease is Alzheimer disease.